No headlines found.
Globe Newswire (Thu, 4-Dec 8:00 AM ET)
Globe Newswire (Tue, 2-Dec 8:00 AM ET)
Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion
Globe Newswire (Wed, 5-Nov 6:00 AM ET)
Aclarion Wins "Rising Star" at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH
Globe Newswire (Wed, 22-Oct 6:00 AM ET)
Globe Newswire (Tue, 14-Oct 6:09 AM ET)
Globe Newswire (Mon, 13-Oct 6:00 AM ET)
Globe Newswire (Tue, 7-Oct 6:00 AM ET)
Aclarion Presents at LSI Europe '25 Highlighting Nociscan Technology and Key Value Drivers
Globe Newswire (Wed, 1-Oct 7:17 AM ET)
First Patients Enrolled at UHealth - University of Miami in Aclarion's Pivotal CLARITY Trial
Globe Newswire (Thu, 25-Sep 6:00 AM ET)
Aclarion - Warrant trades on the stock market under the symbol ACONW.
As of December 24, 2025, ACONW stock price was flat at $0.04 with million shares trading.
ACONW has a beta of -1.08, meaning it tends to be less sensitive to market movements. ACONW has a correlation of 0.02 to the broad based SPY ETF.
ACONW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, ACONW traded as high as $.42 and as low as $.01.
ACONW has outperformed the market in the last year with a return of +82.7%, while the SPY ETF gained +17.0%. In the last 3 month period, ACONW beat the market returning +30.8%, while SPY returned +4.1%. However, in the most recent 2 weeks ACONW has underperformed the stock market by returning -11.7%, while SPY returned +1.1%.
ACONW support price is $.03 and resistance is $.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACONW shares will trade within this expected range on the day.
